Bay Street News, November, 2019

CAMBRIDGE, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) — Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality […]

DALLAS and FORT WORTH, Texas, Nov. 08, 2019 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company […]

iMC activation enhances innate NK cell cytotoxicity against tumor cell lines in vitroMC activity enhances the efficacy of CAR-NK cells […]

 SITC presentation builds on data at ASCO in June, adding evidence supporting a new immuno-oncology approach with CPI-006 via activation […]

CDMO Business Achieves 37% Growth in 2019 Year to Date Revenues; Consolidated Company Achieves Profitability from Operations, Turns Cash Flow […]

Updated Results from NT-001 Trial of NEO-PV-01 Demonstrate Prolonged Progression-Free and Overall Survival vs. Historical Benchmark DataAdvanced Process Development Supports […]

– Akoustis Expanding Pre-Production of Ultra-Wideband 5.6 GHz Filter for Tri-Band WiFi CPE –– 5.6 GHz Filter Works in Tandem […]

Houston, Nov. 08, 2019 (GLOBE NEWSWIRE) — ENGlobal Corporation (NASDAQ:ENG)Bay Street News

GERMANTOWN, MD, Nov. 08, 2019 (GLOBE NEWSWIRE) —  Orgenesis Inc. (Nasdaq: ORGS) (“Orgenesis” or the “Company”), a leading cell and […]

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2019 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, […]